Information for investors

News Release

<< Back
Cambrex to Present at Upcoming Investor Conferences in September
August 30, 2017

EAST RUTHERFORD, N.J., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that company management will present at the following investor conferences in September:

2017 Wells Fargo Healthcare Conference
Date:  Wednesday, September 6, 2017
Time:  4:10 p.m. EDT
Location:  Boston, MA

Baird's 2017 Global Healthcare Conference
Date:  Thursday, September 7, 2017
Time:  10:15 a.m. EDT
Location:  New York, NY

The live audio webcasts and slide presentations can be accessed from the Cambrex website at in the Investors section under "Webcasts & Presentations", and replays will be available for 90 days after the live events conclude. 

About Cambrex 
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.  For more information, please visit

Contact:    Stephanie LaFiura
                  Investor Relations Associate
Phone:      201.804.3037

Primary Logo

Cambrex Corporation

Contact information

American Stock Transfer &
Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Phone: 718.921.8275
Fax: 718.921.8331
Stephanie LaFiura
Investor Relations Associate
Phone: 201-804-3037
Fax: 201-804-9852